Literature DB >> 10771834

Cushing's syndrome.

V Bhatia1.   

Abstract

Endogenous Cushing's Syndrome (CS) is a relatively uncommon disease in children. The etiology is more often a primary adrenal cause in infants and younger children, and corticotroph adenoma in older ones. Diagnostic evaluation must be stepwise and methodical, aimed at first confirming the presence of the disease, and then looking for the etiology. The management should preferably be carried out at a centre which is experienced in the management of CS. Recent advances, including MRI, sensitive ACTH assays, inferior petrosal sinus sampling (IPSS) and transsphenoidal surgery (TSS) have dramatically improved the care of children with CS. However, the issue of high recurrence rates after TSS in children remains to be tackled. The prognosis of adrenal carcinoma still remains, dismal.

Entities:  

Mesh:

Year:  1997        PMID: 10771834     DOI: 10.1007/bf02752441

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  18 in total

1.  Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.

Authors:  T Mengden; P Hubmann; J Müller; P Greminger; W Vetter
Journal:  Clin Investig       Date:  1992-07

2.  Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome.

Authors:  M R Flack; E H Oldfield; G B Cutler; M H Zweig; J D Malley; G P Chrousos; D L Loriaux; L K Nieman
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

3.  The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives.

Authors:  D H Streeten; C T Stevenson; T G Dalakos; J J Nicholas; L G Dennick; H Fellerman
Journal:  J Clin Endocrinol Metab       Date:  1969-09       Impact factor: 5.958

Review 4.  Cushing's disease in children.

Authors:  M C Leinung; D Zimmerman
Journal:  Endocrinol Metab Clin North Am       Date:  1994-09       Impact factor: 4.741

5.  The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.

Authors:  L K Nieman; G B Cutler; E H Oldfield; D L Loriaux; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1989-07       Impact factor: 5.958

Review 6.  Cushing's syndrome and the nodular adrenal gland.

Authors:  M H Samuels; D L Loriaux
Journal:  Endocrinol Metab Clin North Am       Date:  1994-09       Impact factor: 4.741

7.  Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.

Authors:  A W Meikle
Journal:  Clin Endocrinol (Oxf)       Date:  1982-04       Impact factor: 3.478

8.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

9.  Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population.

Authors:  W A Hall; M G Luciano; J L Doppman; N J Patronas; E H Oldfield
Journal:  Ann Intern Med       Date:  1994-05-15       Impact factor: 25.391

10.  Single dose dexamethasone suppression test in children: dose relationship to body size.

Authors:  P C Hindmarsh; C G Brook
Journal:  Clin Endocrinol (Oxf)       Date:  1985-07       Impact factor: 3.478

View more
  2 in total

1.  Cushing's disease developing independently from acute lymphoblastic leukemia.

Authors:  Masaki Yamamoto; Tsukasa Hori; Naoki Hatakeyama; Keita Igarashi; Hotaka Kamasaki; Takako Takeuchi; Yoshihiro Minamida; Masahiko Wanibuchi; Hiroyuki Tsutsumi; Nobuhiro Suzuki
Journal:  Indian J Pediatr       Date:  2014-09       Impact factor: 1.967

Review 2.  Cushing syndrome.

Authors:  Bibek Bista; Nancy Beck
Journal:  Indian J Pediatr       Date:  2013-09-24       Impact factor: 1.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.